Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$171.02B | 43.7x | 0.06 | NT$514 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$79.37B | 13.2x | 0.23 | NT$769 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$61.61B | 11.3x | 0.29 | NT$235 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.5% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$30.81B | -11x | 0.19 | NT$40 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$28.60B | -1,990x | -21.14 | NT$39.70 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$28.36B | -22.8x | 2.76 | NT$59.30 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$27.94B | -65.7x | -3.73 | NT$165.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39% Upside | Upgrade to Pro+ | |
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$26.83B | 14.8x | -2.73 | NT$344 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | |
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$22.41B | 30.9x | 3.96 | NT$411.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$20.81B | -99x | 2 | NT$76.20 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$19.21B | -25.6x | -3.29 | NT$62.90 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$18.80B | 12.1x | 0.36 | NT$75.60 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$17.50B | 15.6x | 4.26 | NT$206.50 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.1% Upside | Upgrade to Pro+ | |
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$16.46B | 13.4x | 0.41 | NT$61.80 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$16.14B | -6.1 | NT$49.10 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$15.50B | 20.3x | 3.41 | NT$34.05 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.7% Upside | Upgrade to Pro+ | |
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.56B | -210x | -5.26 | NT$115.50 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.05B | 18x | 2.66 | NT$86 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$13.72B | 56x | -1.6 | NT$17.35 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.3% Upside | Upgrade to Pro+ | |
Handa Pharmas | TPEX | Healthcare | Pharmaceuticals | NT$13.29B | 24.9x | -0.75 | NT$84 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.10B | 7.4x | 0.01 | NT$91.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.6% Upside | Upgrade to Pro+ | |
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$13.07B | -6.8x | -0.21 | NT$54.80 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$12.59B | 17x | -0.59 | NT$132 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Medeon Biodesign | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$11.33B | -14.5x | -0.38 | NT$123 | 9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -35% Downside | Upgrade to Pro+ | |
Lin Bio | TPEX | Healthcare | Pharmaceuticals | NT$11.21B | -14.6x | 8.01 | NT$137 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$10.40B | 12.7x | -2.08 | NT$58.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$10.09B | -7.4x | 0.42 | NT$65.20 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Orthopedic | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$10.08B | 18.2x | 0.55 | NT$104.50 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11% Upside | Upgrade to Pro+ | |
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$9.07B | -3.6x | 0.05 | NT$34.50 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$8.61B | -40.7x | -1.07 | NT$40.25 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
St.Shine Optical | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$8.57B | 11.7x | 0.43 | NT$170 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.3% Upside | Upgrade to Pro+ | |
Formosa Lab | Taiwan | Healthcare | Pharmaceuticals | NT$8.48B | 22.7x | 0.04 | NT$70.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
SCI Pharmtech | Taiwan | Healthcare | Pharmaceuticals | NT$8.33B | 15.9x | 0.21 | NT$69.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.1% Upside | Upgrade to Pro+ | |
Bioteque | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$8.32B | 15.5x | 1.34 | NT$120 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.03B | -17.4x | -0.87 | NT$38.75 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADIM | Taiwan | Healthcare | Pharmaceuticals | NT$7.73B | -27.4x | -0.54 | NT$18.35 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.3% Upside | Upgrade to Pro+ | |
CHC Healthcare | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$7.31B | 37.2x | -1.04 | NT$42.80 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.5% Upside | Upgrade to Pro+ | |
Taigen BioPharmas | TPEX | Healthcare | Pharmaceuticals | NT$7.11B | -141.4x | 1.01 | NT$9.90 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orient Pharma | TPEX | Healthcare | Pharmaceuticals | NT$7.10B | 66.3x | 0.17 | NT$31.85 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SVBI | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$7.05B | 27.7x | 1.04 | NT$97.70 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Easywell Biomedical | TPEX | Healthcare | Pharmaceuticals | NT$6.97B | -118.9x | -2.3 | NT$55.90 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Savior Lifetec | TPEX | Healthcare | Pharmaceuticals | NT$6.79B | 13.5x | 0.03 | NT$21.40 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Hospital Supply | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.71B | 14.2x | 1.03 | NT$92.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.8% Upside | Upgrade to Pro+ | |
Panion BF Biotech | Taiwan | Healthcare | Pharmaceuticals | NT$6.53B | 60x | 5.41 | NT$76.20 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.1% Upside | Upgrade to Pro+ | |
Hi-Clearance | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.39B | 18.4x | -6.16 | NT$143.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sinphar | Taiwan | Healthcare | Pharmaceuticals | NT$5.91B | 19.3x | -0.81 | NT$32.65 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.1% Downside | Upgrade to Pro+ | |
Icares Medicus | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.21B | 41.1x | 1.62 | NT$122.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intai Tech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.02B | 19.1x | -1.19 | NT$101 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Onyx Healthcare | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$4.74B | 34.1x | -0.75 | NT$121.50 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionime | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$4.50B | -53.8x | 0.11 | NT$73.70 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |